FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091552383> ?p ?o ?g. }

• W2091552383 endingPage "2520" @default.
• W2091552383 startingPage "2512" @default.
• W2091552383 abstract "Glomerular injury is characterized by mesangial cell (MC) proliferation and matrix formation. We sought to determine if reducing the activity of cyclin-dependent kinase 2 (CDK2) with the purine analogue, Roscovitine, decreased MC proliferation in vitro and in vivo. Roscovitine (25 microM) inhibited FCS-induced proliferation (P < 0.0001) in cultured MC. Rats with experimental mesangial proliferative glomerulonephritis (Thy1 model) were divided into two groups. A prevention group received daily intraperitoneal injections of Roscovitine in DMSO (2.8 mg/kg) starting at day 1. A treatment group received daily Roscovitine starting at day 3, when MC proliferation was established. Control Thy1 rats received DMSO alone. MC proliferation (PCNA +/OX7 + double immunostaining) was reduced by > 50% at days 5 and 10 in the Roscovitine prevention group, and at day 5 in the treatment group (P < 0.0001). Early administration of Roscovitine reduced immunostaining for collagen type IV, laminin, and fibronectin at days 5 and 10 (r = 0.984; P < 0.001), which was associated with improved renal function (urinary protein/creatinine, blood urea nitrogen, P < 0.05). We conclude that reducing the activity of CDK2 with Roscovitine in experimental glomerulonephritis decreases cell proliferation and matrix production, resulting in improved renal function, and may be a useful therapeutic intervention in disease characterized by proliferation." @default.
• W2091552383 created "2016-06-24" @default.
• W2091552383 creator A5012532551 @default.
• W2091552383 creator A5047698585 @default.
• W2091552383 creator A5075527652 @default.
• W2091552383 creator A5090098701 @default.
• W2091552383 date "1997-11-15" @default.
• W2091552383 modified "2023-10-13" @default.
• W2091552383 title "Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist." @default.
• W2091552383 cites W1547325391 @default.
• W2091552383 cites W1969939692 @default.
• W2091552383 cites W1970709922 @default.
• W2091552383 cites W1971140803 @default.
• W2091552383 cites W1971740245 @default.
• W2091552383 cites W1980279458 @default.
• W2091552383 cites W1980879551 @default.
• W2091552383 cites W1984640964 @default.
• W2091552383 cites W1987774572 @default.
• W2091552383 cites W1988171238 @default.
• W2091552383 cites W1988460287 @default.
• W2091552383 cites W1997080687 @default.
• W2091552383 cites W1998156838 @default.
• W2091552383 cites W2001670639 @default.
• W2091552383 cites W2006239014 @default.
• W2091552383 cites W2007137412 @default.
• W2091552383 cites W2015066175 @default.
• W2091552383 cites W2015446431 @default.
• W2091552383 cites W2027558915 @default.
• W2091552383 cites W2029080338 @default.
• W2091552383 cites W2033465719 @default.
• W2091552383 cites W2039901479 @default.
• W2091552383 cites W2049849016 @default.
• W2091552383 cites W2060671555 @default.
• W2091552383 cites W2074409447 @default.
• W2091552383 cites W2089528428 @default.
• W2091552383 cites W2098412103 @default.
• W2091552383 cites W2116911322 @default.
• W2091552383 cites W2135129680 @default.
• W2091552383 cites W2138697269 @default.
• W2091552383 cites W2143060667 @default.
• W2091552383 cites W2152028923 @default.
• W2091552383 cites W2174838038 @default.
• W2091552383 cites W2182390629 @default.
• W2091552383 cites W2301131921 @default.
• W2091552383 cites W2400040529 @default.
• W2091552383 cites W2417092456 @default.
• W2091552383 doi "https://doi.org/10.1172/jci119793" @default.
• W2091552383 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/508451" @default.
• W2091552383 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9366565" @default.
• W2091552383 hasPublicationYear "1997" @default.
• W2091552383 type Work @default.
• W2091552383 sameAs 2091552383 @default.
• W2091552383 citedByCount "132" @default.
• W2091552383 countsByYear W20915523832012 @default.
• W2091552383 countsByYear W20915523832013 @default.
• W2091552383 countsByYear W20915523832014 @default.
• W2091552383 countsByYear W20915523832015 @default.
• W2091552383 countsByYear W20915523832016 @default.
• W2091552383 countsByYear W20915523832017 @default.
• W2091552383 countsByYear W20915523832018 @default.
• W2091552383 countsByYear W20915523832019 @default.
• W2091552383 countsByYear W20915523832021 @default.
• W2091552383 countsByYear W20915523832023 @default.
• W2091552383 crossrefType "journal-article" @default.
• W2091552383 hasAuthorship W2091552383A5012532551 @default.
• W2091552383 hasAuthorship W2091552383A5047698585 @default.
• W2091552383 hasAuthorship W2091552383A5075527652 @default.
• W2091552383 hasAuthorship W2091552383A5090098701 @default.
• W2091552383 hasBestOaLocation W20915523831 @default.
• W2091552383 hasConcept C126322002 @default.
• W2091552383 hasConcept C134018914 @default.
• W2091552383 hasConcept C189165786 @default.
• W2091552383 hasConcept C2778176769 @default.
• W2091552383 hasConcept C2780091579 @default.
• W2091552383 hasConcept C2780306776 @default.
• W2091552383 hasConcept C2780368995 @default.
• W2091552383 hasConcept C2780688133 @default.
• W2091552383 hasConcept C55493867 @default.
• W2091552383 hasConcept C62112901 @default.
• W2091552383 hasConcept C71924100 @default.
• W2091552383 hasConcept C86492073 @default.
• W2091552383 hasConcept C86803240 @default.
• W2091552383 hasConceptScore W2091552383C126322002 @default.
• W2091552383 hasConceptScore W2091552383C134018914 @default.
• W2091552383 hasConceptScore W2091552383C189165786 @default.
• W2091552383 hasConceptScore W2091552383C2778176769 @default.
• W2091552383 hasConceptScore W2091552383C2780091579 @default.
• W2091552383 hasConceptScore W2091552383C2780306776 @default.
• W2091552383 hasConceptScore W2091552383C2780368995 @default.
• W2091552383 hasConceptScore W2091552383C2780688133 @default.
• W2091552383 hasConceptScore W2091552383C55493867 @default.
• W2091552383 hasConceptScore W2091552383C62112901 @default.
• W2091552383 hasConceptScore W2091552383C71924100 @default.
• W2091552383 hasConceptScore W2091552383C86492073 @default.
• W2091552383 hasConceptScore W2091552383C86803240 @default.
• W2091552383 hasIssue "10" @default.
• W2091552383 hasLocation W20915523831 @default.
• W2091552383 hasLocation W20915523832 @default.

• next